Can the dose of osimertinib/osimertinib be increased after resistance?

When patients develop resistance to osimertinib/osimertinib (Osimertinib), dose adjustment is usually not the solution. The development of drug resistance may be related to mutations or adaptive changes in tumor cells, and increasing drug doses may not be effective in overcoming drug resistance and may increase the toxic side effects of the drug. Therefore, it is generally not recommended to simply increase the dose of osimertinib/osimertinib to combat drug resistance.

For patients who are resistant to osimertinib/osimertinib, it is more appropriate to discuss and develop new treatment options with their doctors. Here are some possible alternative treatment options:

1.Switch to other targeted drugs: If the patient develops resistance toosimertinib/osimertinib, you can consider switching to other targeted drugs, such as Standard first- or second-generation EGFR inhibitors, such as gefitinib or erlotinib.

2.Combination chemotherapy: After resistance develops, combination chemotherapy may become an option. Chemotherapy drugs work by different mechanisms than osimertinib/osimertinib and therefore can help overcome resistance.

3.Immunotherapy: For some patients, especially those who expressPD-L1, immunotherapy may be an effective alternative. Attack tumor cells by activating the patient's own immune system.

4.Clinical trials: Participation in a clinical trial may be an effective option, especially for patients who are resistant to existing treatment options. Clinical trials may provide opportunities for new drugs or treatment strategies.

When formulating a new treatment plan, doctors usually consider the patient's condition, treatment history, genotype, physiological status, and potential adverse reactions, and discuss and decide the most appropriate treatment option with the patient.

In general, increasing the dose is usually not an appropriate solution for patients who are resistant to osimertinib/osimertinib. Working with physicians to explore new treatment options may lead to more effective management of drug resistance, improved treatment efficacy, and improved patient outcomes.